Skip to main content
. 2020 Feb 11;2020(2):CD001122. doi: 10.1002/14651858.CD001122.pub5

Palomba 2010.

Methods Randomised trial conducted in Italy
Timing: February 2003 to May 2004
Participants 50 participants
Inclusion: Anovulatory, clomiphene‐resistant, with PCOS, seeking pregnancy
Exclusion: < 18 or > 35 years, BMI > 35 kg/m2, neoplastic, metabolic, endocrine, hepatic, renal , and cardiovascular disorders, or other concurrent medical illnesses; and current or previous use of any drug that affected hormone levels, metabolism or appetite. Organic or pelvic diseases, previous pelvic surgery, suspected peritoneal factor infertility/ subfertility, and tubal or male‐factor infertility or subfertility that was excluded by hysterosalpingogram and semen analysis. Wanting to start a diet or a specific programme of physical activity, cigarette smokers or alcoholic beverage abusers
Interventions LOD followed by 6 cycles of observation (n = 25), versus
Clomiphene citrate (incremental dose) plus metformin (850 mg increasing to 1700g daily) for 6 cycles (n = 25)
Follow‐up for 6 months
Outcomes Live birth, pregnancy rates, multiple pregnancy, miscarriage, ovulation rate, adverse events, compliance, cost
Notes Conflict of interest: not stated
Clinical trial registration number: NCT00558077
No funding
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "achieved using online software (www.randomization.it)"
Allocation concealment (selection bias) Low risk Concealed in sealed dark envelopes until the interventions were assigned
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk No details but blinding unlikely due to differences in the interventions
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk No details provided
Incomplete outcome data (attrition bias) 
 All outcomes Low risk 3 women (1 in the LOD group and 2 in the CC + metformin group) were lost to follow‐up because they missed a follow‐up visit
Selective reporting (reporting bias) Low risk We found the registered protocol on ClinicalTrials.gov (NCT00558077). All the outcomes mentioned in the protocol were presented in the published report
Other bias Low risk No evidence of other risk of bias